AmnioGraft, Learn More

BIO-TISSUE, founded in 1997, is the industry leader in regenerative tissue engineering fueled by its desire to develop and deliver high-quality and innovative regenerative wound healing solutions to eyecare providers and their patients. AmnioGraft®, AmnioGuard™, and PROKERA® are cryopreserved amniotic membrane grafts processed using the CryoTek™ Method to ensure that the tissue is able to deliver anti-inflammatory, anti-angiogenic, anti-scarring, and wound healing actions. learn more » 

  • News And Events
  • Media Press Kit
  • More Information

04.24.2013

Bio-Tissue Participates in Vision Source Annual Members Meeting

- Meeting marks the company’s expansion into primary eye care for the treatment of mild to moderate indications -


 

Bio-Tissue Hosts Key Educational Events at the American Society of Cataract and Refractive Surgery

- Prominent speakers to discuss new options for treating ocular surface diseases -


 

Bio-Tissue Reaches Milestone of Shipping 15,000th PROKERA Device

-Only FDA cleared therapeutic device that reduces inflammation and promotes healing -

01.28.2013

Bio-Tissue Announces Introduction of Cliradex®

-New preservative-free, all natural lid and lash cleanser for the treatment of various eye disorders -

01.14.2013

Bio-Tissue Appoints New Senior Director of Marketing and Sales Operations

- Corlette DeVeaux Joins Bio-Tissue from Alcon-Novartis -

12.11.2012

AmnioGraft® Available for the Ocular Treatment of Stevens-Johnson Syndrome 

-New larger designed size provides more coverage to help heal the ocular surface -

11.19.2012 

Bio-Tissue Appoints New Senior Vice President, Sales and Marketing 

- Tom Daniells joins Bio-Tissue from Optos -


Visit our new PROKERA® Microsite: www.prokerainfo.com